Monkeypox history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


==Physical Examination==
==History==
===Vital Signs===
===Vital Signs===



Revision as of 20:45, 14 June 2022

Monkeypox Microchapters

Home

Patient Info

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Monkeypox

Differentiating Monkeypox from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Monkeypox history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Monkeypox history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Monkeypox history and symptoms

CDC on Monkeypox history and symptoms

Monkeypox history and symptoms in the news

Blogs on Monkeypox history and symptoms

Directions to Hospitals Treating Monkeypox

Risk calculators and risk factors for Monkeypox history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Bassel Almarie, M.D.

Overview

History

Vital Signs

Diagnostic Criteria

Interim clinical, laboratory and epidemiologic criteria for case classification — U.S. Monkeypox Response, May 2022

Clinical and laboratory classification Criteria
Suspected New characteristic rash* OR
Meets one of the epidemiologic criteria and has high clinical suspicion† for monkeypox
Probable No suspicion of other recent orthopoxvirus exposure (e.g., Vaccinia virus in ACAM2000 vaccination) AND demonstration of the presence of
•     Orthopoxvirus DNA by polymerase chain reaction testing of a clinical specimen OR
•     Orthopoxvirus using immunohistochemical or electron microscopy testing methods

OR

•     Detectable levels of antiorthopoxvirus IgM antibody during the period of 4–56 days after rash onset
Confirmed Demonstration of the presence of Monkeypox virus DNA by polymerase chain reaction testing or next-generation sequencing of a clinical specimen

OR

Isolation of Monkeypox virus in culture from a clinical specimen